Health care costs related to home spirometry in the eICE randomized trial

Natalie Franz, Hannah Rapp,Ryan N Hansen,Laura S Gold,Christopher H Goss, Noah Lechtzin,Larry G Kessler

Journal of Cystic Fibrosis（2022）

引用 2|浏览19

暂无评分

摘要

•Home spirometry can help track lung health to intervene early in pulmonary exacerbations.•The eICE trial showed no differences in FEV1 but identified health care use differences.•Outpatient visit costs were significantly higher comparing users to non-users of home spirometry.•However, overall health care costs were similar in users and non-users of home spirometry.

查看译文

关键词

Cystic fibrosis,Pulmonary exacerbations,Home spirometry,Healthcare cost, Cost effectiveness

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要